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Abstract: 
There is a high prevalence of depression among left ventricular assist device patients, who present with 
an increased risk for suicidality given access to means via the device either with nonadherence or 
disconnection. Suicidality via device nonadhrence/disconnection is an under-researched clinical issue, 
as paradoxically this life-saving procedure can also provide a method of lethal means to patients with 
significant mental health concerns. 
A case study is used to highlight the course of an attempted suicide by ventricular assistive device 
nonadherence. Clinical implications and recommendations for practice include a thorough 
psychological evaluation pre-surgery, monitoring quality of life and coping styles before and after 
placement, psychological testing, outlining specific suicide protocols, psychiatric care considerations for 
patients with highly specialized medical devices, and related ethical concerns. 
Keywords: Behavioral disciplines and activities, Health care facilities, manpower, and services, 
Cardiovascular System, Behavior and Behavior mechanisms, Pathological Conditions, signs and 
symptoms 
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Introduction 
There are over 10 000 individuals in the United States living with a left ventricular assist 
device (LVAD) to treat end-stage heart failure.1   The prevalence of depression in end-stage heart 
failure is high, with estimates ranging from 11-70%,2  while prevalence rates of depression of the 
general US population are estimated to be about 4.5%.3 Living with an LVAD poses a unique set 
of psychological challenges, including adjustment to an implanted mechanical device and 
reduced independence. Chronically or terminally ill patients with access to nonviolent means, 
such as disconnecting and LVAD device, who experience depression are at increased risk for 
suicide4. 
Clinical relevancy and practice issues are discussed below. 
Clinical Relevancy to Practice 
Mr. G is a 55-year old male with nonischemic cardiomyopathy, an implantable 
cardioverter-defibrillator (ICD), pulmonary hypertension, obesity, and obstructive sleep apnea 
implanted with an LVAD at a large urban medical center. Preceding his LVAD placement, he 
underwent a psychological evaluation, and unremarkable psychiatric history was notable for mild 
depression and anxiety. 
Following LVAD placement, Mr. G adjusted poorly to the associated lifestyle changes, 
such as an intensive medical regiment, and decreased independence, and his mood deteriorated. 
Mr. G’s caregivers, on whom he increasingly relied, were unable to adequately care for him, 
triggering social isolation, reduced sense of purpose, anhedonia, amotivation, fatigue, and 
nonspecific pain. Mr. G.’s medical team became concerned about his decline and referred him 
for follow-up with the in-house psychologist, who subsequently diagnosed him with major 
depressive disorder and generalized anxiety disorder. Mr. G underwent psychiatric treatment 
including psychiatric medical management and psychotherapy with limited success. 
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Progress in Transplantation 
Mr. G endorsed suicidal ideation with plan 7 months following his LVAD implantation, 
stating he intended to take out his LVAD batteries to stop his heart or discontinue his 
anticoagulant medications to cause a life-threatening clot. Mr. G was psychiatrically hospitalized 
for this reason on 6 separate occasions over a 2-year period. Psychiatric hospitalizations were 
typically housed on a medical floor due to the need to manage his LVAD device by trained 
personnel, which psychiatric floors lacked. Following his 5th psychiatric hospitalization, he 
reported to his treating psychologist “I took my time changing the batteries [on my LVAD] and 
my defibrillator went off 8 times” in an active attempt to end his life. He noted the pain from the 
ICD shocks was his only barrier to completing suicide. As a result of continued depression and 
hopelessness, Mr. G initiated intentional nonadherence with his anticoagulation regiment and 
restarted smoking cigarettes in an attempt to increase the likelihood of ending his life. When he 
was subsequently psychiatrically admitted, his INR was significantly sub-therapeutic, confirming 
this follow-through of his threat of intentional nonadherence with his anticoagulation regimen. 
At present, the patient continues to be followed by the advanced heart failure clinic as 
well as a community based mental health center for psychiatric care. His mood and medical 
status are closely monitored for instability; however, he does not currently meet criteria for 
another psychiatric or medical hospitalization. 
Practice Issues: Gaps in Current Practice 
While suicide completion is obviously of paramount concern, ongoing suicidality and 
suicide attempts can also be devastating due to psychological and physiological sequelae in 
LVAD patients. Depression and related suicidality can impact successful recovery from surgery, 
as well as dysregulation of the autonomic and parasympathetic nervous systems affecting 
cardiovascular functioning.2
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Pre-surgical Psychosocial Evaluation 
To address the potential for suicidality in LVAD patients, the medical team must include 
mental health expertise throughout the work-up, placement, and follow-up process. While many 
patients undergoing an LVAD implantation already a complete a psychological and/or 
psychosocial evaluation, the literature does not provide firm guidelines on evaluations, surgical 
recommendations, and interventions for depression and suicidality in LVAD patients. 
Consensus-based recommendations indicate that uncontrolled severe psychiatric illness, 
substance abuse, or active suicidality are high risk and predict premature morbidity and mortality 
among LVAD patients.5 Advanced heart failure teams should include mental health professionals 
such as a psychologists, psychiatrists, and medical social workers to help assess LVAD 
candidates prior to implantation, monitor their course, and provide intervention when necessary 
for psychiatric or psychosocial difficulties. To facilitate this process, many validated brief 
measures may be used by the medical team for evaluation of depression/suicidality and 
psychiatric wellbeing, summarized in Table 1 from a common reference text.6 
In parallel to the work-up for solid organ transplant, it might be appropriate to treat the 
LVAD as a prosthetic organ and evaluate the patient’s understanding of the impact of the device, 
required lifestyle changes, social and functional limitations, and maintenance requirements. 
Reframing LVAD treatment as a trade-off for a subset of medical problems (ie heart failure), for 
a new subset (eg coagulation therapy, intensive self-monitoring), instead of curative intervention, 
may help mitigate expectations and set patients up for the long-term emotional success. 
Suicidality Management in VAD Patients 
For medical teams to successfully manage suicidality, the team must understand the risk 
factors for suicidality and elements leading to a suicide attempt. The majority of suicide attempts 
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Progress in Transplantation 
occur in patients suffering from depression, characterized by low mood, anhedonia, 
hopelessness, and worthlessness. Additionally, risk factors of suicidality include limited social 
support, access to means, and medical illness, the last notably present in many LVAD recipients. 
In addition to a psychological distress, there is a threshold a patient must psychologically 
overcome to proceed with the suicide attempt. This threshold is lower for soft methods (ie 
inaction, such as medication nonadherence) compared to hard methods (eg shooting oneself).7 As 
LVAD implantation may introduce easily accessible soft means to suicide, patients should be 
monitored for signs of depression and associated risk factors routinely. Open communication and 
rapport in the patient-doctor relationship are also protective factors. Appropriate psychiatric 
referrals, including a combination of medication management and counseling is the gold 
standard of care, but access can be limited, often necessitating the assistance of non-psychiatrist 
physicians in prescribing psychiatric medications. Further education of the treatment team can 
boost team skill and confidence in handling suicidality. Finally, pre-surgical, post-implantation, 
and ongoing annual psychological evaluations can help monitor LVAD patients for early risk 
factors and provide early intervention to manage depression and suicidality. 
In situations where psychiatric hospitalization is indicated, such as imminent threat or 
actual suicide attempt, many inpatient units may not be equipped to properly evaluate or admit a 
patient with an LVAD. An attempt characterized by medical nonadherence with LVAD, such as 
failing to change batteries, may inadvertently be construed as accidental by untrained 
professionals. Moreover, many inpatient units do not have personnel that are trained in managing 
LVADs, rendering them unable to take medical responsibility of an LVAD patient that would 
otherwise be admitted. System wide education and policy change may be necessary to aid 
patients with highly specialized medical and mechanical needs obtain high quality psychiatric 
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care.  In the meantime, the medical team will need to collaborate on intensive management of 
psychiatrically ill patients with LVADs, requiring a strong multidisciplinary team for optimal 
outcomes, a proposed team illustrated in Figure 1. 
Ethical Issues in Suicidality 
In patients with LVADs, suicidality must be differentiated from terminal patients who do 
not wish to continue medical treatment due to poor quality of life or suffering. For most patients, 
a LVAD is a necessary life-saving treatment for end-stage heart failure. Swetz and colleagues 
argue that patients have a right to refuse treatment, viewing LVAD disconnection as a 
permissible choice in some instances.8 In such cases, appropriate psychiatric evaluation is 
necessary to differentiate the intent of this request as euthanasia via ceasing life-prolonging 
medical intervention from reversible psychiatric illness such as depression. Complete consensus 
with the entire medical team, patient, and the patient’s family should be obtained. In patients 
with poor quality of life, collaboration of the LVAD team with hospice, palliative care, and or 
ethics consultants may be appropriate to help relieve suffering and fulfill the patient’s wishes.9 
Summary and Implications for Practice 
Suicide by LVAD disconnection has been documented in the literature.7 Ventricular 
assistive devices provide access to lethal means as individuals depend on their implanted life- 
saving device. Ending ones’ life can be immediate and passive if they do not adhere closely to a 
strict treatment regimen. Although LVAD implantation itself has been associated with reduced 
depression and improved quality of life10 some patients may adjust poorly and their worsening 
depression combined with easy access to passive lethal means may increase their risk for suicide. 
Thorough psychological evaluation, routine follow-up, and targeted interventions for depressed 
or suicidal patients are a critical part of competent care for LVAD patients. Practitioners should 
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Construct Measure Name 
Depression/Suicidality 
Beck Depression Inventory 
Hospital Anxiety and Depression Scale 
Patient Health Questionnaire Scale 
Coping and Health Status 
General Health Questionnaire 
Short Form 36 Health Survey 
Minnesota Living with Heart Failure Questionnaire 
Personality 
Minnesota Multiphasic Personality Inventory 
Personality Assessment Inventory 
Quality of Life 
World Health Organization Quality of Life Scale 
Quality of Life Scale 
Social Support 
The Duke-University of North Carolina Functional Social 
Support Questionnaire 
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Mental Health 
Professional 
Psychology/Psychiatry 
Social Work 
Evaluation, 
Psychotherapy, 
Medicaiton, Admissions 
Primay Care 
Provide History and 
Background at Baseline, 
Evaluate and Manage 
Psychiatric State in Early 
Stages 
Nursing Staff/Coordinator 
Monitoring Symptoms & 
Compliance Behaviors, 
Education 
LVAD 
Patient 
Psychiatric Illness & Suicidality 
Financial Navigator 
Mitigate financial 
stressors 
Cardiologist/Surgeon 
Evaluate Risk-benefit 
Ratio, Monitor Patient 
Safety, Triage Medical 
Crisis 
Pharmacist 
Monitor safe profile for 
medications, mitigate risk 
for overdose or self-harm 
